Explore the Latest Adalimumab Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Adalimumab Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Adalimumab Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Adalimumab Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Adalimumab Tenders and beyond.
14150181DC 021 2015 Unified procurement dictionary 33600000-6 Pharmaceutical products 33650000-1 General anti-infectives for systemic use vaccines antineoplastic agents and immunomodulaCountry: UkraineDeadline18 Aug 20265876497Germany Pharmaceutical products Abschluss eines nicht exklusiven Rabattvertrages nach 130a Abs 8 SGB V zu Arzneimitteln mit dem Wirkstoff Adalimumab ATC-Code L04AB04Country: GermanyDeadline27 Aug 20266343944Germany Pharmaceutical products Abschluss nicht-exklusiver Rabattvereinbarungen nach 130 a Abs 8 SGB V mit dem Wirkstoff AdalimumabCountry: GermanyDeadline10 Nov 20266874468Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Adalimumab ATC-Code nach WHOCountry: GermanyDeadline30 Nov 20268307695Title : Open House Biologics Discount Agreements 2025-19 - AdalimumabCountry: GermanyDeadline31 Jul 20278635255Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Adalimumab ATC L04AB04Country: GermanyDeadline03 Jul 20278646745Open house pharmaceuticals advice treaties adalimumab atc l04ab04Country: GermanyDeadline03 Jul 20279421287Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Adalimumab ATC L04AB04Country: GermanyDeadline31 Aug 20279443815Medicines with the active ingredient adalimumab atc l04ab04Country: GermanyDeadline31 Aug 202711416477Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Adalimumab ATC L04AB04Country: GermanyDeadline31 Jan 202812346543Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Adalimumab ATC L04AB04Country: GermanyDeadline31 Jan 202812364050Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Adalimumab ATC L04AB04Country: GermanyDeadline31 Mar 202812389815Open house drug discount agreements for the active ingredient adalimumab atc l04ab04Country: GermanyDeadline01 Apr 202812842438Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Adalimumab ATC L04AB04Country: GermanyDeadline30 Apr 202813481598Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient adalimumabCountry: GermanyDeadline30 Nov 202613568468Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient adalimumabCountry: GermanyDeadline30 Nov 202613830245Open house Arzneimittelrabattverträge Adalimumab, ATC L04AB04Country: GermanyDeadline02 Jul 202814166866Adalimumab solution for injection 40 mg 0 4 ml in a pre-filled single-dose syringe DK 021 2015 - 33600000-6 Pharmaceutical productsCountry: UkraineDeadline19 Aug 202614249539Adalimumab solution for injection 40 mg 0 4 ml in a pre-filled single-dose syringeCountry: UkraineDeadline12 Aug 2026
